ProQR Therapeutics (PRQR) Non-cash Items (2022 - 2024)
ProQR Therapeutics' (PRQR) quarterly Non-cash Items came in at -$29.7 million in Q3 2024, down 201.54% year-on-year from $29.3 million in Q4 2023, and down 21.25% quarter-over-quarter from -$24.5 million in Q2 2024.
ProQR Therapeutics (PRQR) Non-cash Items (2022 - 2024) Analysis & Trends
ProQR Therapeutics has disclosed Non-cash Items across 3 years of filings, most recently posting -$29.7 million for Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | ProQR Therapeutics | 7.27 Mn | -100.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -29.70 Mn |
| Sep 30, 2024 | -29.70 Mn |
| Jun 30, 2024 | -24.50 Mn |
| Jun 30, 2024 | -24.50 Mn |
| Mar 31, 2024 | -16.44 Mn |
| Mar 31, 2024 | -16.44 Mn |
| Sep 30, 2023 | 29.25 Mn |
| Sep 30, 2023 | 29.25 Mn |
| Jun 30, 2023 | 36.49 Mn |
| Jun 30, 2023 | 36.49 Mn |
| Mar 31, 2023 | 48.01 Mn |
| Mar 31, 2023 | 48.01 Mn |
| Sep 30, 2022 | -47.49 Mn |
| Sep 30, 2022 | -47.49 Mn |
| Jun 30, 2022 | -35.03 Mn |
| Jun 30, 2022 | -35.03 Mn |